Pharma News - Chemdiv

Merck KGaA to Pay Over $3 Million to Patients After Thyroid Drug Formulation Change

France’s highest court has ordered European drugmaker Merck KGaA to pay more than $3.6 million to patients who received a thyroid drug Levothyrox (levothyroxine sodium) with diminished quality f...

Medicines Patent Pool Inks Deal With 35 Companies for Generic Paxlovid

The United Nations-backed Medicines Patent Pool (MPP) has signed agreements with 35 companies to manufacture generic versions of Pfizer’s COVID-19 therapeutic Paxlovid (nirmatrelvir). ...

RINVOQ® (upadacitinib) Receives FDA Approval for the Treatment of Adults with Moderately to Severely Active Ulcerative Colitis

AbbVie (NYSE: ABBV) today announced that the U.S. Food and Drug Administration (FDA) has approved RINVOQ® (upadacitinib) for the treatment of adults with moderately to severely active ulcerative c...

Roche Posts Positive Results for Evrysdi in Type 2 and 3 Spinal Muscular Atrophy

Roche has published long-term data confirming the efficacy and safety of its drug Evrysdi (risdiplam) in patients age two to 25 who have type 2 or type 3 spinal muscular atrophy, a rare and often ...

Allarity Therapeutics Requests Type C Meeting With FDA to Discuss Dovitinib in Third-Line RCC

Allarity Therapeutics, Inc. has filed a formal request with the FDA to hold a Type C meeting where they can discuss possible clinical paths to support the approval of dovitinib in renal cell carci...

Exelixis Shuts Down sNDA Plans for Cabometyx Following Negative Phase 3 Study Results

Exelixis announced that it has scrapped plans to submit a supplemental new drug application (sNDA) for its cancer therapy Cabometyx (cabozantinib) for the treatment of newly diagnosed hepatocellul...

FDA Approves First Generic of Symbicort to Treat Asthma and COPD

The U.S. Food and Drug Administration approved the first generic of Symbicort (budesonide and formoterol fumarate dihydrate) Inhalation Aerosol for the treatment of two common pulmonary health con...

Nektar Shares Halve on Cancer Trial Failure

Biotech Nektar Therapeutics and its partner Bristol Myers Squibb said early Monday that their cancer drug known as bempeg had failed in a trial in melanoma patients. ...

Are statin side effects all in the mind? International experts recommend ways to improve adherence to statin therapy

For the first time, an international group of experts has issued recommendations to doctors about how to distinguish between true side effects caused by statins that have been prescribed in order ...

Ready, set…GO! Scientists discover a brain circuit that triggers the execution of planned movement

The discovery, published in the scientific journal Cell, results from a collaboration of scientists at the Max Planck Florida Institute for Neuroscience, HHMI's Janelia Research Campus, the Allen ...

Is it 'Pre-Alzheimer's' or normal aging? Poll finds many Americans unclear

You regularly can't remember where you left your phone or your book. You keep missing appointments. You often lose your train of thought during conversation.

FDA declines approval for AstraZeneca’s chronic rhinosinusitis antibody

The US Food and Drug Administration (FDA) has declined to grant approval to AstraZeneca’s Fasenra (benralizumab) to treat individuals with inadequately controlled chronic rhinosinusitis with nasa...